. Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy. Mol Neurodegener. 2018 Mar 15;13(1):13. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Parkinson’s Treatments Go After Genetic Targets